Guido Benedetti

Guido Benedetti

Auto-generated profile, based on publicly available information

Guido Benedetti

Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2012 in Acta Odontologica Scandinavica
Verified
Journal Article
Closed access
GBGuido Benedetti
Guido Benedetti
Guglielmo CampusGuglielmo Campus
Guglielmo Campus
LSLaura Strohmenger
Laura Strohmenger
PLPeter Lingström
Peter Lingström
Objective. Despite the abundance of evidence linking tobacco consumption to many oral conditions, no systematic review of the relationship with dental caries is available. The main aim of this systematic review was, therefore, to evaluate the effect of tobacco smoking on dental caries in adult smokers. Materials and methods. According to the PRISMA checklist, observational studies published from January 1991 to June 2011 were reviewed. The quality of evidence for each finding was rated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology. Results. Five studies, four related to dental caries and one on oral bacteria activity, were finally included in a qualitative analysis; they were all cross-sectional studies. As a result, the overall quality of evidence was poor, with two articles given a score of very low and three a score of low according to GRADE. Conclusions. Tobacco smoking was found to be associated with an increased risk of dental caries. However, the overall poor quality of studies produced no validation for such an association. Further, more extensive research on this topic and prospective studies are needed.

3 May 2018 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
EMErika Mohr
Erika Mohr
JHJennifer Ann Hughes
Jennifer Ann Hughes
ARAnja Reuter
Anja Reuter
LDLaura Trivino Duran
Laura Trivino Duran
GFGabriella Ferlazzo
Gabriella Ferlazzo
PIPetros Isaakidis
Petros Isaakidis
Experience with delamanid (Dlm) is limited, particularly among HIV-positive individuals. We describe early efficacy and safety data from a programmatic setting in South Africa.This was a retrospective cohort study of patients receiving Dlm-containing treatment regimens between November 2015 and August 2017. We report 12-month interim outcomes, sputum culture conversion (SCC) by months 2 and 6, serious adverse events (SAEs) and QT intervals corrected using the Frederica formula (QTcF).Overall, 103 patients were initiated on Dlm; 79 (77%) were HIV positive. The main indication for Dlm was intolerance to second-line anti-tuberculosis (TB) drugs (n=58, 56%). There were 12 months of follow-up for 46 patients; 28 (61%) had a favourable outcome (cure, treatment completion or culture negativity). Positive cultures were found for 57 patients at Dlm initiation; 16 out of 31 (52%) had SCC within 2 months and 25 out of 31 (81%) within 6 months. There were 67 SAEs reported in 29 patients (28%). There were four instances of QTcF prolongation >500 ms in two patients (2%), leading to permanent discontinuation in one case; however, no cardiac arrhythmias occurred.This large cohort of difficult-to-treat patients receiving Dlm for rifampicin-resistant TB treatment in a programmatic setting with high HIV prevalence had favourable early treatment response and tolerated treatment well. Dlm should remain available, particularly for those who cannot be treated with conventional regimens or with limited treatment options.

1 January 2009 in Acta Odontologica Scandinavica
Verified
Journal Article
Closed access
Guglielmo CampusGuglielmo Campus
Guglielmo Campus
MCMaria Grazia Cagetti
Maria Grazia Cagetti
GSGianluca Sacco
Gianluca Sacco
GBGuido Benedetti
Guido Benedetti
LSLaura Strohmenger
Laura Strohmenger
PLPeter Lingström
Peter Lingström
The aim of our study was to assess the caries risk profile in a group of Sardinian schoolchildren and to compare the outcome with their history of caries. Using the computer-based program "Cariogram", 957 subjects aged 7, 8, and 9 years were enrolled in this cross-sectional study. The children were examined to evaluate dmfs/DMFS and gingival conditions. Data on dietary and oral hygiene habits were collected and saliva was analyzed, including levels of mutans streptococci (MS) and lactobacilli (Lb). Based on the Cariogram profiles, the children were divided into five risk groups in accordance with "chance of avoiding caries". Almost 50% of the children had a low caries risk, while more than a quarter had less than 40% "chance of avoiding caries". A significant linear trend between the five Cariogram categories and dmfs/DMFS was observed in the three age groups (p<0.001). The Cariogram risk profile showed strong correlations to the caries experience of Sardinian schoolchildren and that efforts to reduce caries risk are necessary.

3 April 2019 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
JNJustus Nsio
Justus Nsio
JKJimmy Kapetshi
Jimmy Kapetshi
SMSheila Makiala
Sheila Makiala
FRFrederic Raymond
Frederic Raymond
GTGaston Tshapenda
Gaston Tshapenda
JMJean-Jacques T Muyembe
Jean-Jacques T Muyembe
Background. In 2017, the Democratic Republic of the Congo (DRC) recorded its eighth Ebola virus disease (EVD) outbreak, approximately 3 years after the previous outbreak. Methods. Suspect cases of EVD were identified on the basis of clinical and epidemiological information. Reverse transcription-polymerase chain reaction (RT-PCR) analysis or serological testing was used to confirm Ebola virus infection in suspected cases. The causative virus was later sequenced from a RT-PCR-positive individual and assessed using phylogenetic analysis. Results. Three probable and 5 laboratory-confirmed cases of EVD were recorded between 27 March and 1 July 2017 in the DRC. Fifty percent of cases died from the infection. EVD cases were detected in 4 separate areas, resulting in > 270 contacts monitored. The complete genome of the causative agent, a variant from the Zaireebolavirus species, denoted Ebola virus Muyembe, was obtained using next-generation sequencing. This variant is genetically closest, with 98.73% homology, to the Ebola virus Mayinga variant isolated from the first DRC outbreaks in 1976-1977. Conclusion. A single spillover event into the human population is responsible for this DRC outbreak. Human-to-human transmission resulted in limited dissemination of the causative agent, a novel Ebola virus variant closely related to the initial Mayinga variant isolated in 1976-1977 in the DRC.

29 January 2024 in Water Research
Verified
Journal Article
Open access
LKLene Wulff Krogsgaard
Lene Wulff Krogsgaard
GBGuido Benedetti
Guido Benedetti
AGAina Gudde
Aina Gudde
SRStine Raith Richter
Stine Raith Richter
LRLasse Dam Rasmussen
Lasse Dam Rasmussen
SESteen Ethelberg
Steen Ethelberg
The microbiological analysis of wastewater samples is increasingly used for the surveillance of SARS-CoV-2 globally. We described the setup process of the national SARS-CoV-2 wastewater-based surveillance system in Denmark, presented its main results during the first year of activities, from July 2021 to June 2022, and discussed their operational significance. The Danish SARS-CoV-2 wastewater-based surveillance system was designed to cover 85 % of the population in Denmark and it entailed taking three weekly samples from 230 sites. Samples were RT-qPCR tested for SARS-CoV-2 RNA, targeting the genetic markers N1, N2 and RdRp, and for two faecal indicators, Pepper Mild Mottle Virus and crAssphage. We calculated the weekly SARS-CoV-2 RNA concentration in the wastewater from each sampling site and monitored it in view of the results from individual testing, at the national and regional levels. We attempted to use wastewater results to identify potential local outbreaks, and we sequenced positive wastewater samples using Nanopore sequencing to monitor the circulation of viral variants in Denmark. The system reached its full implementation by October 2021 and covered up to 86.4 % of the Danish population. The system allowed for monitoring of the national and regional trends of SARS-CoV-2 infections in Denmark. However, the system contribution to the identification of potential local outbreaks was limited by the extensive information available from clinical testing. The sequencing of wastewater samples identified relevant variants of concern, in line with results from sequencing of human samples. Amidst the COVID-19 pandemic, Denmark implemented a nationwide SARS-CoV-2 wastewater-based surveillance system that integrated routine surveillance from individual testing. Today, while testing for COVID-19 at the community level has been discontinued, the system is on the frontline to monitor the occurrence and spread of SARS-CoV-2 in Denmark.

1 May 2019 in The International Journal of Tuberculosis and Lung Disease
Verified
Journal Article
Open access
SHS. H. Harouna
S. H. Harouna
NON. Ortuno-Gutierrez
N. Ortuno-Gutierrez
MSM. B. Souleymane
M. B. Souleymane
WKW. Kizito
W. Kizito
SMS. Morou
S. Morou
APA. Piubello
A. Piubello
SETTING Niger National Tuberculosis Programme. OBJECTIVE To describe the outcomes and adverse events (AEs) in a cohort of adults, children and adolescents with multidrug-resistant tuberculosis (MDR-TB) who were treated with the ‘short-course regimen'. DESIGN The regimen comprised an intensive phase of 4–6 months with kanamycin, medium–high dose of isoniazid and prothionamide, and high doses of gatifloxacin, clofazimine, ethambutol and pyrazinamide throughout. Sixty-five patients were treated with a regimen of 12–14 months and 55 patients with a regimen of 9–11 months. RESULTS Of the 120 patients evaluated, 110 (92%) were adults (median age 31 years) and 10 (8%) were children or adolescents (median age 17 years). The treatment success rate was respectively 88% and 83% with the 9-month regimen, and 90% and 75% with the 12-month regimen in adults and children/adolescents. Initial resistance to ethambutol and prothionamide did not affect treatment success rates but resistance to fluoroquinolones did, although this was not statistically significant. Vomiting was the most frequently encountered AE, followed by ototoxicity and hepatotoxicity. AEs experienced were mild or moderate in severity in most patients, and did not lead to treatment interruption. CONCLUSION These results confirm the programmatic effectiveness and tolerability of the shorter regimen in second-line drug-naïve patients.